Navigation Links
Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
Date:2/17/2008

A mathematical model shows that a new wave of drug-resistant HIV is rising among among men in San Francisco who have sex with men and that this trend will continue over the next few years, according to a new study from the UCLA AIDS Institute.

At the same time, the evolution of drug-resistant HIV may have actually reduced the severity of the city's epidemic, saving many men from becoming infected.

The model and its results were unveiled today by UCLA biomathematics professor Sally Blower, director of the Biomedical Modeling Center at the David Geffen School of Medicine at UCLA, during a session on drug-resistant diseases at the annual American Association for the Advancement of Science conference in Boston.

"Our amplification cascade model has been validated by our reconstructions and can now be used to design novel and effective health policies for controlling single-, dual- and triple-class resistant strains of HIV in both resource-rich and resource-constrained countries," said Blower, who is also a member of the UCLA AIDS Institute.

The model enabled the researchers to reconstruct the epidemic's past and predict its future by calculating the evolution of several classes of drug-resistant HIV strains in San Francisco.

The research relied on a novel multi-strain mathematical model called the Amplification Cascade Model to examine the rise between 1987 and 2007 of HIV strains resistant to the three major classes of drugs -- nucleosides (NRTIs), nonnucleosides (NNRTIs) and protease inhibitors (PIs). The model took into account three interacting processes -- transmitted, acquired and amplified resistance -- the last of which refers to amplification of drug-resistant strains in HIV-positive people due to the repeated use of multiple-treatment drug regimens.

The study tracked uninfected individuals; newly infected people in the primary stage of infection; chronically infected individuals
'/>"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel approach strips staph of virulence
2. UCSD research team identifies novel anticancer drug from the sea
3. Novel compound may lessen heart attack damage
4. Novel molecules developed at UB can boost vaccine potency
5. Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
6. Novel vaccine concept developed by scientists at the Wistar Institute
7. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
8. Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology
9. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
10. New method enables design, production of extremely novel drugs
11. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... The inaugural single day event in ... New Otani Tokyo Gardens in Tokyo. Clinical data scientists will ... validation. , The second single day event in China ... in Shanghai. The clinical data scientists attending this event will ... and listings, which display data collected in clinical studies and ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 "The primary purpose ... control," said an inventor from Sacramento, Ca.. "Call lights are ... or left hanging on the IV pole out of the ... the nurse call device whenever they need it, I created ... effectively position the nurse call device within easy reach. The ...
(Date:9/23/2014)... 2014 From first-hand experience, Matthew O'Farrell ... and how it can be treated. , A medically ... in 2006. His platoon sustained multiple attacks resulting in ... diagnosed with combat-related PTSD and honorably discharged from the ... I had distanced myself from my friends and family,” ...
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. 23, 2014 (HealthDay ... providing better care, not more care, ... A new report suggests that,s the direction the ... IMS Institute for Healthcare Informatics in Parsippany, N.J., identifies 10 ... delivery of health care and use of medicines over the ...
(Date:9/23/2014)... What information do patients need ... Forum (NQF) released a report ( http://bit.ly/1DwekE9 ), ... infographic ( http://bit.ly/1tX3lzA ) resulting from an in-depth ... patients define affordability, and what information and changes ... possible healthcare at the lowest possible cost. ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2
... consumption dropped, study found , FRIDAY, June 18 (HealthDay ... may reduce consumption and help lower levels of obesity ... suggests. , Researchers examined what happened during a time ... in Boston increased the price of regular soft drinks ...
... , ... Life sell an extensive range of vitamins supplements and nutritional supplements by top manufacturers ... ... Established in 1999, Vitamins for Life (vitaminsforlife.co.uk) supplies practitioner-grade nutritional supplements that ...
... 2010: Systemic Lupus Erythematosus (SLE) patients from Brazil ... that their rheumatic conditions negatively affect their emotional ... today at EULAR 2010, the Annual Congress of ... Furthermore, findings of the French study specifically revealed ...
... The effects of Systemic Lupus Erythematosus (SLE) may differ ... results of a new study presented today at EULAR ... Rheumatism in Rome, Italy. In particular, the study reinforced ... European subpopulations. Results from a Europe-wide study, involving ...
... Kids Bento ... , ... 18, 2010 -- School’s about to start and so is the mad morning scramble of ... kids’ bento boxes , from Laptop Lunches. They’re ideal for packing fun, wholesome, ...
... ... 360 Degree Guarantee and provide consumers with coverage that extends past the original manufacturer labor ... standard warranty. , ... 18, 2010 -- Treadmill Doctor has announced the introduction of their new 360 ...
Cached Medicine News:Health News:People May Skip Soft Drinks Rather Than Pay More 2Health News:Natural Health Online Retailer VitaminsForLife.co.uk Expands Inventory to Meet UK Demands 2Health News:Natural Health Online Retailer VitaminsForLife.co.uk Expands Inventory to Meet UK Demands 3Health News:Sex lives of patients are negatively affected by rheumatoid arthritis and SLE 2Health News:Sex lives of patients are negatively affected by rheumatoid arthritis and SLE 3Health News:Kids' Lunchboxes Go Bento for Easy Back to School Lunch Making, Thanks to Laptop Lunches 2Health News:Treadmill Doctor 360 Degree Guarantee Extended Service Plans 2
(Date:9/23/2014)... 23, 2014  SI-BONE, Inc., a medical device company ... ® a minimally invasive surgical (MIS) device indicated ... that the U.S. Patent and Trademark Office has awarded ... for the fixation and fusion of bone.  This newly ... tapered distal end that may be placed from one bone across ...
(Date:9/23/2014)... Sept. 23, 2014 Report Details ... you trends, R&D and predicted revenues Do you ... Now get the latest analysis for those cancer ... opportunities and revenue forecasts. Visiongain,s new report ... kinase inhibition and related technology. There avoid missing ...
(Date:9/23/2014)... , Sept. 23, 2014 EnzymeBioSystems (OTCBB: ... along with the process of evaluating an enzyme ... in fighting tumors. In an effort to evaluate this ... with various contract research organizations to enlist their ... the use of an antitumor natural product called ...
Breaking Medicine Technology:SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5EnzymeBioSystems Announces Progress with an Enzyme Compound 2
... today reported financial results for the third quarter ended,September ... Novavax reported a net loss of $9.0 million, or ... $5.0 million net loss, or the,equivalent of $0.08 loss ... For the nine months ended September 30, 2007, the ...
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ) today announced ... non-randomized, open-label, multi-center dose,escalation study of the Company,s ... tumors or non-Hodgkin,s lymphoma (NHL). "We are ... said Pablo,J. Cagnoni, M.D., Chief Medical Officer of ...
Cached Medicine Technology:Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 2Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 3Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 4Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 5Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 6Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: